NEWYou can now listen to Fox News articles!

The Trump administration is targeting “misleading drug advertisements” by initiating rule making to close a 1997 loophole that enables drug advertisers to conceal safety risks in broadcast and digital ads.

The Department of Health and Human Services (HHS) and the Federal Drug Administration (FDA) sent thousands of warning letters across the pharmaceutical industry on Tuesday. Sources familiar with the letter told Fox that companies who practice widespread advertising like Hims/Hers are among those receiving the notice.

Fox News Digital also obtained a copy of a letter sent to a pharmaceutical company, which outlines concerns that “patients are not seeing a fair balance of the information regarding a drug product” and directing the company to “

See Full Page